Weiguang Gu
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients.
Journal: Diagnostic pathology
Published: July 08, 2023
Apatinib successfully administered in malignant tumour patients with severe hypotension: a case series, literature review, and considerations for treatment.
Journal: The Journal of international medical research
Published: June 30, 2023
Retracted: Anticancer Activity of Phloretin Against Human Gastric Cancer Cell Lines Involves Apoptosis, Cell Cycle Arrest, and Inhibition of Cell Invasion and JNK Signalling Pathway.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 21, 2022
EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-mutated NSCLC: A Prospective, Randomized, Exploratory Study.
Journal: Cancer research and treatment
Published: November 01, 2022
Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor-informed assay.
Journal: Cancer medicine
Published: August 30, 2022
Case report: EGFR-mutant lung adenocarcinoma with the TP53 and RB1 mutations showed resistance to TKI therapy.
Journal: Annals of palliative medicine
Published: July 02, 2021
Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma.
Journal: Frontiers in oncology
Published: January 26, 2021
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy.
Journal: Translational lung cancer research
Published: September 21, 2020
Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma.
Journal: Translational lung cancer research
Published: July 18, 2020
Efficacy and safety of apatinib as third- or further-line therapy for patients with advanced NSCLC: a retrospective study.
Journal: Therapeutic advances in medical oncology
Published: May 29, 2020
Comprehensive molecular profiling of extrahepatic cholangiocarcinoma in Chinese population and potential targets for clinical practice.
Journal: Hepatobiliary surgery and nutrition
Published: January 14, 2020
Last Updated: 09/26/2026